nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—CA2—osteoporosis	0.603	1	CbGaD
Methyclothiazide—CA2—Zoledronate—osteoporosis	0.242	1	CbGbCtD
Methyclothiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.00593	0.217	CbGpPWpGaD
Methyclothiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—osteoporosis	0.00545	0.199	CbGpPWpGaD
Methyclothiazide—CA4—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00471	0.172	CbGpPWpGaD
Methyclothiazide—CA1—Reversible hydration of carbon dioxide—CA2—osteoporosis	0.00433	0.158	CbGpPWpGaD
Methyclothiazide—Quinethazone—CA2—osteoporosis	0.000832	0.145	CrCbGaD
Methyclothiazide—Cramp muscle—Alendronate—osteoporosis	0.000811	0.00661	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.000808	0.00658	CcSEcCtD
Methyclothiazide—Cramp muscle—Ibandronate—osteoporosis	0.00079	0.00643	CcSEcCtD
Methyclothiazide—Pancreatitis—Estropipate—osteoporosis	0.000775	0.00631	CcSEcCtD
Methyclothiazide—Cyclothiazide—CA2—osteoporosis	0.000773	0.134	CrCbGaD
Methyclothiazide—Benzthiazide—CA2—osteoporosis	0.000773	0.134	CrCbGaD
Methyclothiazide—Chlorothiazide—CA2—osteoporosis	0.000768	0.133	CrCbGaD
Methyclothiazide—Diclofenamide—CA2—osteoporosis	0.000768	0.133	CrCbGaD
Methyclothiazide—Agranulocytosis—Etidronic acid—osteoporosis	0.00076	0.00619	CcSEcCtD
Methyclothiazide—Anorexia—Calcium Acetate—osteoporosis	0.000754	0.00615	CcSEcCtD
Methyclothiazide—Pancreatitis—Calcitriol—osteoporosis	0.000727	0.00593	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Estropipate—osteoporosis	0.000713	0.00581	CcSEcCtD
Methyclothiazide—Paraesthesia—Calcium Acetate—osteoporosis	0.000711	0.00579	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Alendronate—osteoporosis	0.00071	0.00579	CcSEcCtD
Methyclothiazide—Erythema multiforme—Etidronic acid—osteoporosis	0.000691	0.00563	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.000688	0.00561	CcSEcCtD
Methyclothiazide—Decreased appetite—Calcium Acetate—osteoporosis	0.000688	0.0056	CcSEcCtD
Methyclothiazide—Pneumonia—Raloxifene—osteoporosis	0.000687	0.00559	CcSEcCtD
Methyclothiazide—Pneumonia—Ibandronate—osteoporosis	0.00068	0.00554	CcSEcCtD
Methyclothiazide—Constipation—Calcium Acetate—osteoporosis	0.000677	0.00551	CcSEcCtD
Methyclothiazide—Anorexia—Ergocalciferol—osteoporosis	0.000666	0.00543	CcSEcCtD
Methyclothiazide—Hydroflumethiazide—CA2—osteoporosis	0.000648	0.113	CrCbGaD
Methyclothiazide—Hydrochlorothiazide—CA2—osteoporosis	0.000631	0.11	CrCbGaD
Methyclothiazide—Purpura—Conjugated Estrogens—osteoporosis	0.000627	0.00511	CcSEcCtD
Methyclothiazide—Cramp muscle—Pamidronate—osteoporosis	0.000619	0.00504	CcSEcCtD
Methyclothiazide—Muscle spasms—Etidronic acid—osteoporosis	0.000612	0.00499	CcSEcCtD
Methyclothiazide—Decreased appetite—Ergocalciferol—osteoporosis	0.000608	0.00495	CcSEcCtD
Methyclothiazide—Erythema multiforme—Estropipate—osteoporosis	0.000598	0.00487	CcSEcCtD
Methyclothiazide—Constipation—Ergocalciferol—osteoporosis	0.000598	0.00487	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—COL1A2—osteoporosis	0.000594	0.0217	CbGpPWpGaD
Methyclothiazide—Erythema multiforme—Alendronate—osteoporosis	0.000589	0.0048	CcSEcCtD
Methyclothiazide—Hypersensitivity—Calcium Acetate—osteoporosis	0.000583	0.00475	CcSEcCtD
Methyclothiazide—Leukopenia—Etidronic acid—osteoporosis	0.00057	0.00464	CcSEcCtD
Methyclothiazide—Asthenia—Calcium Acetate—osteoporosis	0.000568	0.00463	CcSEcCtD
Methyclothiazide—Cramp muscle—Zoledronate—osteoporosis	0.000565	0.0046	CcSEcCtD
Methyclothiazide—Trichlormethiazide—CA2—osteoporosis	0.000562	0.0977	CrCbGaD
Methyclothiazide—Erythema multiforme—Calcitriol—osteoporosis	0.000561	0.00457	CcSEcCtD
Methyclothiazide—Pneumonia—Risedronate—osteoporosis	0.00056	0.00456	CcSEcCtD
Methyclothiazide—Malnutrition—Estropipate—osteoporosis	0.000551	0.00449	CcSEcCtD
Methyclothiazide—Cramp muscle—Conjugated Estrogens—osteoporosis	0.000544	0.00443	CcSEcCtD
Methyclothiazide—Diarrhoea—Calcium Acetate—osteoporosis	0.000541	0.00441	CcSEcCtD
Methyclothiazide—Vascular purpura—Estradiol—osteoporosis	0.000541	0.0044	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—WNT1—osteoporosis	0.000539	0.0197	CbGpPWpGaD
Methyclothiazide—Pneumonia—Pamidronate—osteoporosis	0.000532	0.00434	CcSEcCtD
Methyclothiazide—Muscle spasms—Estropipate—osteoporosis	0.000529	0.00431	CcSEcCtD
Methyclothiazide—Malnutrition—Ibandronate—osteoporosis	0.000528	0.0043	CcSEcCtD
Methyclothiazide—Dizziness—Calcium Acetate—osteoporosis	0.000523	0.00426	CcSEcCtD
Methyclothiazide—Muscle spasms—Alendronate—osteoporosis	0.000521	0.00425	CcSEcCtD
Methyclothiazide—Muscle spasms—Raloxifene—osteoporosis	0.000513	0.00418	CcSEcCtD
Methyclothiazide—Pancreatitis—Conjugated Estrogens—osteoporosis	0.000512	0.00417	CcSEcCtD
Methyclothiazide—Muscle spasms—Ibandronate—osteoporosis	0.000508	0.00414	CcSEcCtD
Methyclothiazide—Vomiting—Calcium Acetate—osteoporosis	0.000503	0.0041	CcSEcCtD
Methyclothiazide—Purpura—Estradiol—osteoporosis	0.000502	0.00409	CcSEcCtD
Methyclothiazide—Asthenia—Ergocalciferol—osteoporosis	0.000501	0.00409	CcSEcCtD
Methyclothiazide—Vertigo—Estropipate—osteoporosis	0.000495	0.00403	CcSEcCtD
Methyclothiazide—Agranulocytosis—Pamidronate—osteoporosis	0.000494	0.00403	CcSEcCtD
Methyclothiazide—Vertigo—Alendronate—osteoporosis	0.000487	0.00397	CcSEcCtD
Methyclothiazide—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000485	0.00395	CcSEcCtD
Methyclothiazide—Vertigo—Raloxifene—osteoporosis	0.000479	0.0039	CcSEcCtD
Methyclothiazide—Agitation—Calcitriol—osteoporosis	0.000475	0.00387	CcSEcCtD
Methyclothiazide—Vertigo—Ibandronate—osteoporosis	0.000474	0.00387	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Conjugated Estrogens—osteoporosis	0.000471	0.00384	CcSEcCtD
Methyclothiazide—Nausea—Calcium Acetate—osteoporosis	0.00047	0.00383	CcSEcCtD
Methyclothiazide—Paraesthesia—Etidronic acid—osteoporosis	0.000466	0.0038	CcSEcCtD
Methyclothiazide—Agranulocytosis—Zoledronate—osteoporosis	0.000451	0.00368	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Estropipate—osteoporosis	0.000449	0.00366	CcSEcCtD
Methyclothiazide—Malnutrition—Ethinyl Estradiol—osteoporosis	0.000446	0.00364	CcSEcCtD
Methyclothiazide—Constipation—Etidronic acid—osteoporosis	0.000444	0.00362	CcSEcCtD
Methyclothiazide—Cramp muscle—Estradiol—osteoporosis	0.000435	0.00355	CcSEcCtD
Methyclothiazide—Malnutrition—Risedronate—osteoporosis	0.000435	0.00355	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Ibandronate—osteoporosis	0.000431	0.00351	CcSEcCtD
Methyclothiazide—Muscle spasms—Ethinyl Estradiol—osteoporosis	0.000429	0.0035	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Raloxifene—osteoporosis	0.000426	0.00347	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Calcitriol—osteoporosis	0.000422	0.00344	CcSEcCtD
Methyclothiazide—Muscle spasms—Risedronate—osteoporosis	0.000418	0.00341	CcSEcCtD
Methyclothiazide—Nausea—Ergocalciferol—osteoporosis	0.000415	0.00338	CcSEcCtD
Methyclothiazide—Malnutrition—Pamidronate—osteoporosis	0.000414	0.00337	CcSEcCtD
Methyclothiazide—Urticaria—Etidronic acid—osteoporosis	0.000413	0.00336	CcSEcCtD
Methyclothiazide—Pancreatitis—Estradiol—osteoporosis	0.00041	0.00334	CcSEcCtD
Methyclothiazide—Paraesthesia—Estropipate—osteoporosis	0.000404	0.00329	CcSEcCtD
Methyclothiazide—Anorexia—Calcitriol—osteoporosis	0.000402	0.00328	CcSEcCtD
Methyclothiazide—Muscle spasms—Pamidronate—osteoporosis	0.000398	0.00324	CcSEcCtD
Methyclothiazide—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000395	0.00322	CcSEcCtD
Methyclothiazide—Vertigo—Risedronate—osteoporosis	0.000391	0.00319	CcSEcCtD
Methyclothiazide—Paraesthesia—Ibandronate—osteoporosis	0.000387	0.00315	CcSEcCtD
Methyclothiazide—Constipation—Estropipate—osteoporosis	0.000384	0.00313	CcSEcCtD
Methyclothiazide—Hypersensitivity—Etidronic acid—osteoporosis	0.000383	0.00312	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Estradiol—osteoporosis	0.000381	0.00311	CcSEcCtD
Methyclothiazide—Agitation—Pamidronate—osteoporosis	0.00038	0.0031	CcSEcCtD
Methyclothiazide—Constipation—Alendronate—osteoporosis	0.000379	0.00308	CcSEcCtD
Methyclothiazide—Malnutrition—Zoledronate—osteoporosis	0.000378	0.00308	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Estradiol—osteoporosis	0.000377	0.00307	CcSEcCtD
Methyclothiazide—Pneumonia—Estradiol—osteoporosis	0.000375	0.00305	CcSEcCtD
Methyclothiazide—Decreased appetite—Ibandronate—osteoporosis	0.000375	0.00305	CcSEcCtD
Methyclothiazide—Leukopenia—Pamidronate—osteoporosis	0.00037	0.00302	CcSEcCtD
Methyclothiazide—Constipation—Ibandronate—osteoporosis	0.000369	0.003	CcSEcCtD
Methyclothiazide—Decreased appetite—Calcitriol—osteoporosis	0.000367	0.00299	CcSEcCtD
Methyclothiazide—Malnutrition—Conjugated Estrogens—osteoporosis	0.000364	0.00296	CcSEcCtD
Methyclothiazide—Muscle spasms—Zoledronate—osteoporosis	0.000363	0.00296	CcSEcCtD
Methyclothiazide—Jaundice—Estradiol—osteoporosis	0.000363	0.00296	CcSEcCtD
Methyclothiazide—Constipation—Calcitriol—osteoporosis	0.000361	0.00294	CcSEcCtD
Methyclothiazide—Urticaria—Estropipate—osteoporosis	0.000357	0.00291	CcSEcCtD
Methyclothiazide—Vision blurred—Zoledronate—osteoporosis	0.000356	0.0029	CcSEcCtD
Methyclothiazide—Diarrhoea—Etidronic acid—osteoporosis	0.000355	0.0029	CcSEcCtD
Methyclothiazide—Body temperature increased—Estropipate—osteoporosis	0.000355	0.00289	CcSEcCtD
Methyclothiazide—Urticaria—Alendronate—osteoporosis	0.000352	0.00287	CcSEcCtD
Methyclothiazide—Body temperature increased—Alendronate—osteoporosis	0.00035	0.00285	CcSEcCtD
Methyclothiazide—Muscle spasms—Conjugated Estrogens—osteoporosis	0.00035	0.00285	CcSEcCtD
Methyclothiazide—Agitation—Zoledronate—osteoporosis	0.000347	0.00283	CcSEcCtD
Methyclothiazide—Body temperature increased—Raloxifene—osteoporosis	0.000344	0.0028	CcSEcCtD
Methyclothiazide—Vision blurred—Conjugated Estrogens—osteoporosis	0.000343	0.00279	CcSEcCtD
Methyclothiazide—Urticaria—Ibandronate—osteoporosis	0.000342	0.00279	CcSEcCtD
Methyclothiazide—Body temperature increased—Ibandronate—osteoporosis	0.000341	0.00278	CcSEcCtD
Methyclothiazide—Vertigo—Zoledronate—osteoporosis	0.000339	0.00277	CcSEcCtD
Methyclothiazide—Leukopenia—Zoledronate—osteoporosis	0.000338	0.00276	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Pamidronate—osteoporosis	0.000338	0.00275	CcSEcCtD
Methyclothiazide—Urticaria—Calcitriol—osteoporosis	0.000335	0.00273	CcSEcCtD
Methyclothiazide—Body temperature increased—Calcitriol—osteoporosis	0.000333	0.00272	CcSEcCtD
Methyclothiazide—Hypersensitivity—Estropipate—osteoporosis	0.000331	0.0027	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Pamidronate—osteoporosis	0.000331	0.00269	CcSEcCtD
Methyclothiazide—Vomiting—Etidronic acid—osteoporosis	0.00033	0.00269	CcSEcCtD
Methyclothiazide—Rash—Etidronic acid—osteoporosis	0.000328	0.00267	CcSEcCtD
Methyclothiazide—Dermatitis—Etidronic acid—osteoporosis	0.000327	0.00267	CcSEcCtD
Methyclothiazide—Vertigo—Conjugated Estrogens—osteoporosis	0.000327	0.00266	CcSEcCtD
Methyclothiazide—Hypersensitivity—Alendronate—osteoporosis	0.000326	0.00266	CcSEcCtD
Methyclothiazide—Headache—Etidronic acid—osteoporosis	0.000325	0.00265	CcSEcCtD
Methyclothiazide—Asthenia—Estropipate—osteoporosis	0.000322	0.00263	CcSEcCtD
Methyclothiazide—Anorexia—Pamidronate—osteoporosis	0.000322	0.00262	CcSEcCtD
Methyclothiazide—Paraesthesia—Risedronate—osteoporosis	0.000319	0.0026	CcSEcCtD
Methyclothiazide—Asthenia—Alendronate—osteoporosis	0.000318	0.00259	CcSEcCtD
Methyclothiazide—Hypersensitivity—Ibandronate—osteoporosis	0.000318	0.00259	CcSEcCtD
Methyclothiazide—Erythema multiforme—Estradiol—osteoporosis	0.000316	0.00258	CcSEcCtD
Methyclothiazide—Constipation—Ethinyl Estradiol—osteoporosis	0.000312	0.00254	CcSEcCtD
Methyclothiazide—Hypersensitivity—Calcitriol—osteoporosis	0.000311	0.00253	CcSEcCtD
Methyclothiazide—Asthenia—Ibandronate—osteoporosis	0.000309	0.00252	CcSEcCtD
Methyclothiazide—Nausea—Etidronic acid—osteoporosis	0.000309	0.00251	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Zoledronate—osteoporosis	0.000308	0.00251	CcSEcCtD
Methyclothiazide—Diarrhoea—Estropipate—osteoporosis	0.000307	0.00251	CcSEcCtD
Methyclothiazide—Constipation—Risedronate—osteoporosis	0.000304	0.00247	CcSEcCtD
Methyclothiazide—Paraesthesia—Pamidronate—osteoporosis	0.000303	0.00247	CcSEcCtD
Methyclothiazide—Diarrhoea—Alendronate—osteoporosis	0.000303	0.00247	CcSEcCtD
Methyclothiazide—Asthenia—Calcitriol—osteoporosis	0.000303	0.00247	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Zoledronate—osteoporosis	0.000302	0.00246	CcSEcCtD
Methyclothiazide—Diarrhoea—Raloxifene—osteoporosis	0.000298	0.00243	CcSEcCtD
Methyclothiazide—Dizziness—Estropipate—osteoporosis	0.000297	0.00242	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000297	0.00242	CcSEcCtD
Methyclothiazide—Diarrhoea—Ibandronate—osteoporosis	0.000295	0.0024	CcSEcCtD
Methyclothiazide—Anorexia—Zoledronate—osteoporosis	0.000294	0.0024	CcSEcCtD
Methyclothiazide—Decreased appetite—Pamidronate—osteoporosis	0.000293	0.00239	CcSEcCtD
Methyclothiazide—Dizziness—Alendronate—osteoporosis	0.000293	0.00239	CcSEcCtD
Methyclothiazide—Malnutrition—Estradiol—osteoporosis	0.000291	0.00237	CcSEcCtD
Methyclothiazide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000289	0.00236	CcSEcCtD
Methyclothiazide—Constipation—Pamidronate—osteoporosis	0.000289	0.00235	CcSEcCtD
Methyclothiazide—Diarrhoea—Calcitriol—osteoporosis	0.000289	0.00235	CcSEcCtD
Methyclothiazide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000288	0.00235	CcSEcCtD
Methyclothiazide—Dizziness—Raloxifene—osteoporosis	0.000288	0.00235	CcSEcCtD
Methyclothiazide—Vomiting—Estropipate—osteoporosis	0.000286	0.00233	CcSEcCtD
Methyclothiazide—Dizziness—Ibandronate—osteoporosis	0.000285	0.00232	CcSEcCtD
Methyclothiazide—Rash—Estropipate—osteoporosis	0.000283	0.00231	CcSEcCtD
Methyclothiazide—Dermatitis—Estropipate—osteoporosis	0.000283	0.00231	CcSEcCtD
Methyclothiazide—Anorexia—Conjugated Estrogens—osteoporosis	0.000283	0.00231	CcSEcCtD
Methyclothiazide—Urticaria—Risedronate—osteoporosis	0.000282	0.0023	CcSEcCtD
Methyclothiazide—Headache—Estropipate—osteoporosis	0.000282	0.00229	CcSEcCtD
Methyclothiazide—Vomiting—Alendronate—osteoporosis	0.000281	0.00229	CcSEcCtD
Methyclothiazide—Body temperature increased—Risedronate—osteoporosis	0.000281	0.00229	CcSEcCtD
Methyclothiazide—Muscle spasms—Estradiol—osteoporosis	0.00028	0.00228	CcSEcCtD
Methyclothiazide—Rash—Alendronate—osteoporosis	0.000279	0.00227	CcSEcCtD
Methyclothiazide—Dermatitis—Alendronate—osteoporosis	0.000279	0.00227	CcSEcCtD
Methyclothiazide—Headache—Alendronate—osteoporosis	0.000277	0.00226	CcSEcCtD
Methyclothiazide—Paraesthesia—Zoledronate—osteoporosis	0.000277	0.00226	CcSEcCtD
Methyclothiazide—Vomiting—Raloxifene—osteoporosis	0.000277	0.00226	CcSEcCtD
Methyclothiazide—Rash—Raloxifene—osteoporosis	0.000274	0.00224	CcSEcCtD
Methyclothiazide—Dermatitis—Raloxifene—osteoporosis	0.000274	0.00223	CcSEcCtD
Methyclothiazide—Vomiting—Ibandronate—osteoporosis	0.000274	0.00223	CcSEcCtD
Methyclothiazide—Headache—Raloxifene—osteoporosis	0.000273	0.00222	CcSEcCtD
Methyclothiazide—Rash—Ibandronate—osteoporosis	0.000272	0.00221	CcSEcCtD
Methyclothiazide—Dermatitis—Ibandronate—osteoporosis	0.000271	0.00221	CcSEcCtD
Methyclothiazide—Headache—Ibandronate—osteoporosis	0.00027	0.0022	CcSEcCtD
Methyclothiazide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000268	0.00219	CcSEcCtD
Methyclothiazide—Vomiting—Calcitriol—osteoporosis	0.000268	0.00219	CcSEcCtD
Methyclothiazide—Decreased appetite—Zoledronate—osteoporosis	0.000268	0.00218	CcSEcCtD
Methyclothiazide—Agitation—Estradiol—osteoporosis	0.000268	0.00218	CcSEcCtD
Methyclothiazide—Nausea—Estropipate—osteoporosis	0.000267	0.00218	CcSEcCtD
Methyclothiazide—Body temperature increased—Pamidronate—osteoporosis	0.000267	0.00217	CcSEcCtD
Methyclothiazide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000267	0.00217	CcSEcCtD
Methyclothiazide—Rash—Calcitriol—osteoporosis	0.000266	0.00217	CcSEcCtD
Methyclothiazide—Dermatitis—Calcitriol—osteoporosis	0.000266	0.00217	CcSEcCtD
Methyclothiazide—Headache—Calcitriol—osteoporosis	0.000264	0.00215	CcSEcCtD
Methyclothiazide—Constipation—Zoledronate—osteoporosis	0.000264	0.00215	CcSEcCtD
Methyclothiazide—Nausea—Alendronate—osteoporosis	0.000263	0.00214	CcSEcCtD
Methyclothiazide—Hypersensitivity—Risedronate—osteoporosis	0.000262	0.00213	CcSEcCtD
Methyclothiazide—Vertigo—Estradiol—osteoporosis	0.000262	0.00213	CcSEcCtD
Methyclothiazide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000261	0.00213	CcSEcCtD
Methyclothiazide—Nausea—Raloxifene—osteoporosis	0.000259	0.00211	CcSEcCtD
Methyclothiazide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000258	0.0021	CcSEcCtD
Methyclothiazide—Nausea—Ibandronate—osteoporosis	0.000256	0.00209	CcSEcCtD
Methyclothiazide—Asthenia—Risedronate—osteoporosis	0.000255	0.00208	CcSEcCtD
Methyclothiazide—Constipation—Conjugated Estrogens—osteoporosis	0.000254	0.00207	CcSEcCtD
Methyclothiazide—Nausea—Calcitriol—osteoporosis	0.000251	0.00204	CcSEcCtD
Methyclothiazide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000249	0.00203	CcSEcCtD
Methyclothiazide—Hypersensitivity—Pamidronate—osteoporosis	0.000249	0.00203	CcSEcCtD
Methyclothiazide—Urticaria—Zoledronate—osteoporosis	0.000245	0.002	CcSEcCtD
Methyclothiazide—Body temperature increased—Zoledronate—osteoporosis	0.000244	0.00199	CcSEcCtD
Methyclothiazide—Diarrhoea—Risedronate—osteoporosis	0.000243	0.00198	CcSEcCtD
Methyclothiazide—Asthenia—Pamidronate—osteoporosis	0.000242	0.00197	CcSEcCtD
Methyclothiazide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000241	0.00196	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Estradiol—osteoporosis	0.000238	0.00194	CcSEcCtD
Methyclothiazide—Urticaria—Conjugated Estrogens—osteoporosis	0.000236	0.00192	CcSEcCtD
Methyclothiazide—Dizziness—Risedronate—osteoporosis	0.000235	0.00191	CcSEcCtD
Methyclothiazide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000235	0.00191	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000233	0.00849	CbGpPWpGaD
Methyclothiazide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000232	0.00189	CcSEcCtD
Methyclothiazide—Diarrhoea—Pamidronate—osteoporosis	0.000231	0.00188	CcSEcCtD
Methyclothiazide—Rash—Ethinyl Estradiol—osteoporosis	0.00023	0.00187	CcSEcCtD
Methyclothiazide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000229	0.00187	CcSEcCtD
Methyclothiazide—Headache—Ethinyl Estradiol—osteoporosis	0.000228	0.00186	CcSEcCtD
Methyclothiazide—Hypersensitivity—Zoledronate—osteoporosis	0.000227	0.00185	CcSEcCtD
Methyclothiazide—Vomiting—Risedronate—osteoporosis	0.000226	0.00184	CcSEcCtD
Methyclothiazide—Rash—Risedronate—osteoporosis	0.000224	0.00182	CcSEcCtD
Methyclothiazide—Dermatitis—Risedronate—osteoporosis	0.000224	0.00182	CcSEcCtD
Methyclothiazide—Dizziness—Pamidronate—osteoporosis	0.000223	0.00182	CcSEcCtD
Methyclothiazide—Headache—Risedronate—osteoporosis	0.000222	0.00181	CcSEcCtD
Methyclothiazide—Asthenia—Zoledronate—osteoporosis	0.000221	0.0018	CcSEcCtD
Methyclothiazide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000219	0.00178	CcSEcCtD
Methyclothiazide—Nausea—Ethinyl Estradiol—osteoporosis	0.000216	0.00176	CcSEcCtD
Methyclothiazide—Vomiting—Pamidronate—osteoporosis	0.000215	0.00175	CcSEcCtD
Methyclothiazide—Paraesthesia—Estradiol—osteoporosis	0.000213	0.00174	CcSEcCtD
Methyclothiazide—Asthenia—Conjugated Estrogens—osteoporosis	0.000213	0.00174	CcSEcCtD
Methyclothiazide—Rash—Pamidronate—osteoporosis	0.000213	0.00173	CcSEcCtD
Methyclothiazide—Dermatitis—Pamidronate—osteoporosis	0.000213	0.00173	CcSEcCtD
Methyclothiazide—Headache—Pamidronate—osteoporosis	0.000212	0.00172	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ANXA2—osteoporosis	0.000211	0.00771	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Zoledronate—osteoporosis	0.000211	0.00172	CcSEcCtD
Methyclothiazide—Nausea—Risedronate—osteoporosis	0.000211	0.00172	CcSEcCtD
Methyclothiazide—Decreased appetite—Estradiol—osteoporosis	0.000207	0.00168	CcSEcCtD
Methyclothiazide—Dizziness—Zoledronate—osteoporosis	0.000204	0.00166	CcSEcCtD
Methyclothiazide—Constipation—Estradiol—osteoporosis	0.000203	0.00166	CcSEcCtD
Methyclothiazide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000203	0.00166	CcSEcCtD
Methyclothiazide—Nausea—Pamidronate—osteoporosis	0.000201	0.00163	CcSEcCtD
Methyclothiazide—Dizziness—Conjugated Estrogens—osteoporosis	0.000196	0.0016	CcSEcCtD
Methyclothiazide—Vomiting—Zoledronate—osteoporosis	0.000196	0.0016	CcSEcCtD
Methyclothiazide—Rash—Zoledronate—osteoporosis	0.000194	0.00158	CcSEcCtD
Methyclothiazide—Dermatitis—Zoledronate—osteoporosis	0.000194	0.00158	CcSEcCtD
Methyclothiazide—Headache—Zoledronate—osteoporosis	0.000193	0.00157	CcSEcCtD
Methyclothiazide—Vomiting—Conjugated Estrogens—osteoporosis	0.000189	0.00154	CcSEcCtD
Methyclothiazide—Urticaria—Estradiol—osteoporosis	0.000189	0.00154	CcSEcCtD
Methyclothiazide—Body temperature increased—Estradiol—osteoporosis	0.000188	0.00153	CcSEcCtD
Methyclothiazide—Rash—Conjugated Estrogens—osteoporosis	0.000187	0.00153	CcSEcCtD
Methyclothiazide—Dermatitis—Conjugated Estrogens—osteoporosis	0.000187	0.00152	CcSEcCtD
Methyclothiazide—Headache—Conjugated Estrogens—osteoporosis	0.000186	0.00152	CcSEcCtD
Methyclothiazide—Nausea—Zoledronate—osteoporosis	0.000183	0.00149	CcSEcCtD
Methyclothiazide—Nausea—Conjugated Estrogens—osteoporosis	0.000176	0.00144	CcSEcCtD
Methyclothiazide—Hypersensitivity—Estradiol—osteoporosis	0.000175	0.00143	CcSEcCtD
Methyclothiazide—Asthenia—Estradiol—osteoporosis	0.000171	0.00139	CcSEcCtD
Methyclothiazide—Diarrhoea—Estradiol—osteoporosis	0.000163	0.00133	CcSEcCtD
Methyclothiazide—Dizziness—Estradiol—osteoporosis	0.000157	0.00128	CcSEcCtD
Methyclothiazide—Vomiting—Estradiol—osteoporosis	0.000151	0.00123	CcSEcCtD
Methyclothiazide—Rash—Estradiol—osteoporosis	0.00015	0.00122	CcSEcCtD
Methyclothiazide—Dermatitis—Estradiol—osteoporosis	0.00015	0.00122	CcSEcCtD
Methyclothiazide—Headache—Estradiol—osteoporosis	0.000149	0.00121	CcSEcCtD
Methyclothiazide—Nausea—Estradiol—osteoporosis	0.000141	0.00115	CcSEcCtD
Methyclothiazide—CA4—Metabolism—FDPS—osteoporosis	0.00013	0.00474	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PKM—osteoporosis	0.00013	0.00474	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—MYC—osteoporosis	0.00013	0.00474	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PKM—osteoporosis	0.000125	0.00455	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FDPS—osteoporosis	0.000125	0.00455	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GPD2—osteoporosis	0.000123	0.0045	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PGLS—osteoporosis	0.000123	0.0045	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FDPS—osteoporosis	0.000119	0.00436	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PKM—osteoporosis	0.000119	0.00436	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PGLS—osteoporosis	0.000118	0.00431	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPD2—osteoporosis	0.000118	0.00431	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPD2—osteoporosis	0.000113	0.00413	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PGLS—osteoporosis	0.000113	0.00413	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PNP—osteoporosis	0.000113	0.00411	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ATIC—osteoporosis	0.000113	0.00411	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PNP—osteoporosis	0.000108	0.00394	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ATIC—osteoporosis	0.000108	0.00394	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ATIC—osteoporosis	0.000104	0.00378	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PNP—osteoporosis	0.000104	0.00378	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—OXCT1—osteoporosis	9.58e-05	0.0035	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CA2—osteoporosis	9.58e-05	0.0035	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MGLL—osteoporosis	9.33e-05	0.00341	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—OXCT1—osteoporosis	9.18e-05	0.00335	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MGLL—osteoporosis	8.95e-05	0.00327	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—OXCT1—osteoporosis	8.8e-05	0.00321	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CA2—osteoporosis	8.8e-05	0.00321	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.73e-05	0.00319	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MGLL—osteoporosis	8.58e-05	0.00313	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—IDH2—osteoporosis	7.93e-05	0.0029	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ADCY5—osteoporosis	7.92e-05	0.00289	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—IDH2—osteoporosis	7.61e-05	0.00278	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP27A1—osteoporosis	7.46e-05	0.00272	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—IDH2—osteoporosis	7.29e-05	0.00266	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ACP5—osteoporosis	7.26e-05	0.00265	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP27A1—osteoporosis	7.15e-05	0.00261	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ACP5—osteoporosis	6.96e-05	0.00254	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP27A1—osteoporosis	6.86e-05	0.0025	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TPI1—osteoporosis	6.75e-05	0.00246	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ACP5—osteoporosis	6.67e-05	0.00244	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TPI1—osteoporosis	6.47e-05	0.00236	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—P4HB—osteoporosis	6.34e-05	0.00232	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GAPDH—osteoporosis	6.23e-05	0.00227	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TPI1—osteoporosis	6.2e-05	0.00226	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—P4HB—osteoporosis	6.08e-05	0.00222	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—RAP1A—osteoporosis	6.06e-05	0.00221	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GAPDH—osteoporosis	5.97e-05	0.00218	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—P4HB—osteoporosis	5.83e-05	0.00213	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—RAP1A—osteoporosis	5.81e-05	0.00212	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GAPDH—osteoporosis	5.72e-05	0.00209	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—RAP1A—osteoporosis	5.57e-05	0.00204	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ENO1—osteoporosis	4.9e-05	0.00179	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PSMA2—osteoporosis	4.83e-05	0.00176	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PSMA5—osteoporosis	4.83e-05	0.00176	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ENO1—osteoporosis	4.7e-05	0.00172	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PSMA2—osteoporosis	4.63e-05	0.00169	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PSMA5—osteoporosis	4.63e-05	0.00169	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ENO1—osteoporosis	4.51e-05	0.00165	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PSMA5—osteoporosis	4.44e-05	0.00162	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PSMA2—osteoporosis	4.44e-05	0.00162	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP19A1—osteoporosis	3.92e-05	0.00143	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP19A1—osteoporosis	3.76e-05	0.00137	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP19A1—osteoporosis	3.6e-05	0.00132	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ADCY5—osteoporosis	3.2e-05	0.00117	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GPX1—osteoporosis	3.19e-05	0.00117	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ADCY5—osteoporosis	3.07e-05	0.00112	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GPX1—osteoporosis	3.06e-05	0.00112	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTHFR—osteoporosis	2.94e-05	0.00108	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ADCY5—osteoporosis	2.94e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GPX1—osteoporosis	2.93e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MTHFR—osteoporosis	2.82e-05	0.00103	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTHFR—osteoporosis	2.71e-05	0.000988	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—POMC—osteoporosis	2.36e-05	0.00086	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—POMC—osteoporosis	2.26e-05	0.000824	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—POMC—osteoporosis	2.16e-05	0.00079	CbGpPWpGaD
